Clinical Trials Directory

Trials / Conditions / Mild to Moderate Alzheimer's Disease

Mild to Moderate Alzheimer's Disease

10 registered clinical trials studyying Mild to Moderate Alzheimer's Disease — 1 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingThe Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease
NCT07457125
Xuanwu Hospital, BeijingPhase 1 / Phase 2
UnknownEfficacy and Safety of Near Infrared Light Therapy for Alzheimer's Disease
NCT06008639
Danyang Huichuang Medical Equipment Co., Ltd.N/A
CompletedGV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)
NCT05189210
GemVax & KaelPhase 2
CompletedTesting the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease
NCT03867253
Oryzon Genomics S.A.Phase 2
CompletedEfficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease
NCT03625622
AriBio Co., Ltd.Phase 2
CompletedA Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.
NCT03507790
Cognition TherapeuticsPhase 2
CompletedStudy of LM11A-31-BHS in Mild-moderate AD Patients
NCT03069014
PharmatrophiX Inc.Phase 1 / Phase 2
CompletedNextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer'
NCT02703636
Novartis PharmaceuticalsPhase 4
CompletedThe PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study
NCT02256306
Stanford UniversityN/A
Completed4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease
NCT01039701
AstraZenecaPhase 2